UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Extrahepatic Manifestations of Hepatitis C: A Meta-analysis of Prevalence, Quality of Life, and Economic Burden

Gastroenterology (New York, N.Y. 1943), 2016-06, Vol.150 (7), p.1599-1608

2016

Volltextzugriff (PDF)

Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity‐matched cohort study

Journal of internal medicine, 2019-12, Vol.286 (6), p.711-722

2019

Volltextzugriff (PDF)

Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD

Hepatology (Baltimore, Md.), 2018-02, Vol.67 (2), p.492-504

2018

Volltextzugriff (PDF)

Non-steroidal anti-inflammatory drug-associated acute kidney injury: does short-term NSAID use pose a risk in hospitalized patients?

European journal of clinical pharmacology, 2021-09, Vol.77 (9), p.1409-1417

2021

Volltextzugriff (PDF)

Proton pump inhibitors and risk of liver cancer and mortality in patients with chronic liver disease: a systematic review and meta-analysis

European journal of clinical pharmacology, 2020-06, Vol.76 (6), p.851-866

2020

Volltextzugriff (PDF)

Machine learning algorithms for predicting direct‐acting antiviral treatment failure in chronic hepatitis C: An HCV‐TARGET analysis

Hepatology (Baltimore, Md.), 2022-08, Vol.76 (2), p.483-491

2022

Volltextzugriff (PDF)

A Nationwide Study of Inpatient Admissions, Mortality, and Costs for Patients with Cirrhosis from 2005 to 2015 in the USA

Digestive diseases and sciences, 2020-05, Vol.65 (5), p.1520-1528

2020

Volltextzugriff (PDF)

Impact of Direct-acting Antivirals on Hepatocellular Carcinoma and Mortality Among Medicaid Beneficiaries With Hepatitis C

Medical care, 2023-08, Vol.61 (8), p.505-513

2023

Volltextzugriff (PDF)

Direct Medical Costs and Utilization of Health Care Services to Treat Pneumonia in the United States: An Analysis of the 2007–2011 Medical Expenditure Panel Survey

Clinical therapeutics, 2015-07, Vol.37 (7), p.1466-1476.e1

2015

Volltextzugriff (PDF)

Disparities in Access to Hepatitis C Treatment Among Arizona Medicaid Beneficiaries With Chronic Hepatitis C

Medical care, 2023-02, Vol.61 (2), p.81-86

2023

Volltextzugriff (PDF)

Impact of hepatitis C virus treatment on the risk of non‐hepatic cancers among hepatitis C virus‐infected patients in the US

Alimentary pharmacology & therapeutics, 2020-11, Vol.52 (10), p.1592-1602

2020

Volltextzugriff (PDF)

Utilization of chronic lung disease treatment before the respiratory syncytial virus season as palivizumab prophylaxis qualifier in the American Academy of Pediatrics Guidelines

European journal of pediatrics, 2022-02, Vol.181 (2), p.841-845

2022

Volltextzugriff (PDF)

Efficacy and safety of dipeptidyl peptidase-4 inhibitors in type 2 diabetes: meta-analysis

The Annals of pharmacotherapy, 2012-11, Vol.46 (11), p.1453-1469

2012

Volltextzugriff (PDF)

Evaluation of machine learning algorithms for predicting direct-acting antiviral treatment failure among patients with chronic hepatitis C infection

Scientific reports, 2022-10, Vol.12 (1), p.18094-9, Article 18094

2022

Volltextzugriff (PDF)

Trends in anemia care in non-dialysis-dependent chronic kidney disease (CKD) patients in the United States (2006-2015)

BMC nephrology, 2018-11, Vol.19 (1), p.318-318, Article 318

2018

Volltextzugriff (PDF)

Economic and clinical burden of viral hepatitis in California: A population-based study with longitudinal analysis

PloS one, 2018-04, Vol.13 (4), p.e0196452-e0196452

2018

Volltextzugriff (PDF)

Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists

Cardiovascular diabetology, 2018-07, Vol.17 (1), p.102-102, Article 102

2018

Volltextzugriff (PDF)

Correction: Economic and clinical burden of viral hepatitis in California: A population-based study with longitudinal analysis

PloS one, 2018-12, Vol.13 (12), p.e0209715-e0209715

2018

Volltextzugriff (PDF)

Trends in Recommended Screening and Monitoring Tests for Users of HIV Pre-Exposure Prophylaxis Before and During the COVID-19 Pandemic

AJPM Focus, 2023-12, Vol.2 (4), p.100134-100134, Article 100134

2023

Volltextzugriff (PDF)

Cost-Effectiveness of Expanded Newborn Screening in Texas

Value in health, 2012-07, Vol.15 (5), p.613-621

2012

Volltextzugriff (PDF)

Direct‐Acting Antiviral Treatment Use Remains Low Among Florida Medicaid Beneficiaries With Chronic Hepatitis C

Hepatology communications, 2021-02, Vol.5 (2), p.203-216

2021

Volltextzugriff (PDF)

Comparative effectiveness and safety of direct oral anticoagulants versus warfarin among patients with recurrent venous thromboembolism

Clinical and translational science, 2023-06, Vol.16 (6), p.946-954

2023

Volltextzugriff (PDF)

Trends in pharmacotherapy utilization among patients with heart failure with preserved ejection fraction

American heart journal plus, 2023-02, Vol.26, p.100259-100259, Article 100259

2023

Volltextzugriff (PDF)

Comparative effectiveness and safety of extended anticoagulant therapy among Medicare beneficiaries with venous thromboembolism

Clinical and translational science, 2023-01, Vol.16 (1), p.128-139

2023

Volltextzugriff (PDF)

155: EFFECTS OF DIRECT-ACTING ANTIVIRALS FOR HEPATITIS C VIRUS ON HEPATOCELLULAR CARCINOMA AND MORTALITY AMONG MEDICAID BENEFICIARIES

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-1118-S-1119

2022

Volltextzugriff (PDF)

1 – 25 von 142

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(132)
Mit Volltextzugriff
(117)

Publikationsform

Artikel
(140)
Tagungsberichte
(2)

Sprache

Englisch
(142)

Erscheinungsjahr

n.n

Thema

Science & Technology
(106)
Life Sciences & Biomedicine
(99)
Humans
(72)
Female
(48)
Male
(47)
Middle Aged
(39)
Retrospective Studies
(39)
Pharmacology & Pharmacy
(38)
Aged
(35)
Adult
(31)
United States
(25)
Patients
(22)
Medicare
(20)
Health Care Sciences & Services
(17)
Antiviral Agents - Therapeutic Use
(16)
Hepatitis C
(16)
Hepatitis C, Chronic - Drug Therapy
(15)
United States - Epidemiology
(14)
Adolescent
(13)
General & Internal Medicine
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Extrahepatic Manifestations of Hepatitis C: A Meta-analysis of Prevalence, Quality of Life, and Economic Burden

Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity‐matched cohort study

Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD

Non-steroidal anti-inflammatory drug-associated acute kidney injury: does short-term NSAID use pose a risk in hospitalized patients?

Proton pump inhibitors and risk of liver cancer and mortality in patients with chronic liver disease: a systematic review and meta-analysis

Machine learning algorithms for predicting direct‐acting antiviral treatment failure in chronic hepatitis C: An HCV‐TARGET analysis

A Nationwide Study of Inpatient Admissions, Mortality, and Costs for Patients with Cirrhosis from 2005 to 2015 in the USA

Impact of Direct-acting Antivirals on Hepatocellular Carcinoma and Mortality Among Medicaid Beneficiaries With Hepatitis C

Direct Medical Costs and Utilization of Health Care Services to Treat Pneumonia in the United States: An Analysis of the 2007–2011 Medical Expenditure Panel Survey

Disparities in Access to Hepatitis C Treatment Among Arizona Medicaid Beneficiaries With Chronic Hepatitis C

Impact of hepatitis C virus treatment on the risk of non‐hepatic cancers among hepatitis C virus‐infected patients in the US

Utilization of chronic lung disease treatment before the respiratory syncytial virus season as palivizumab prophylaxis qualifier in the American Academy of Pediatrics Guidelines

Efficacy and safety of dipeptidyl peptidase-4 inhibitors in type 2 diabetes: meta-analysis

Evaluation of machine learning algorithms for predicting direct-acting antiviral treatment failure among patients with chronic hepatitis C infection

Trends in anemia care in non-dialysis-dependent chronic kidney disease (CKD) patients in the United States (2006-2015)

Economic and clinical burden of viral hepatitis in California: A population-based study with longitudinal analysis

Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists

Correction: Economic and clinical burden of viral hepatitis in California: A population-based study with longitudinal analysis

Trends in Recommended Screening and Monitoring Tests for Users of HIV Pre-Exposure Prophylaxis Before and During the COVID-19 Pandemic

Cost-Effectiveness of Expanded Newborn Screening in Texas

Direct‐Acting Antiviral Treatment Use Remains Low Among Florida Medicaid Beneficiaries With Chronic Hepatitis C

Comparative effectiveness and safety of direct oral anticoagulants versus warfarin among patients with recurrent venous thromboembolism

Trends in pharmacotherapy utilization among patients with heart failure with preserved ejection fraction

Comparative effectiveness and safety of extended anticoagulant therapy among Medicare beneficiaries with venous thromboembolism

155: EFFECTS OF DIRECT-ACTING ANTIVIRALS FOR HEPATITIS C VIRUS ON HEPATOCELLULAR CARCINOMA AND MORTALITY AMONG MEDICAID BENEFICIARIES

Suchergebnisse filtern